On September 1, 2021 Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, reported that management will participate in the following investor conferences in September (Press release, Bicycle Therapeutics, SEP 1, 2021, View Source [SID1234587101]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Goldman Sachs Eleventh Annual Biotech Symposium on Tuesday, September 7, 2021
H.C. Wainwright 23rd Annual Global Investment Conference on Monday, September 13, 2021; pre-recorded presentation available on demand at 7:00 a.m. ET
Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021
Cantor Virtual Global Healthcare Conference on Monday, September 27, 2021; fireside chat at 11:20 a.m. ET
A live webcast of the fireside chats and replay of the pre-recorded presentation will be accessible in the Investors & Media section of Bicycle’s website at www.bicycletherapeutics.com. Archived replays of the webcasts will be available for 30 days following the pre-recorded presentation and fireside chat dates.